Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2
- 22 February 2022
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 145 (8) , 626-628
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Targeting inflammation in atherosclerosis — from experimental insights to the clinicNature Reviews Drug Discovery, 2021
- Colchicine in Patients with Chronic Coronary DiseaseNew England Journal of Medicine, 2020
- Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionNew England Journal of Medicine, 2019
- The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristicsAmerican Heart Journal, 2019
- Residual Inflammatory RiskJACC, 2019